Identification of a bifunctional lipopolysaccharide sialyltransferase in Haemophilus influenzae - Incorporation of disialic acid by Fox, Kate L. et al.
Identification of a Bifunctional Lipopolysaccharide
Sialyltransferase in Haemophilus influenzae
INCORPORATIONOFDISIALIC ACID*□S
Received for publication,March 13, 2006, and in revised form, October 26, 2006 Published, JBC Papers in Press,October 27, 2006, DOI 10.1074/jbc.M602314200
Kate L. Fox‡1, Andrew D. Cox§, Michel Gilbert§, WarrenW. Wakarchuk§, Jianjun Li§, Katherine Makepeace‡,
James C. Richards§, E. Richard Moxon‡2, and Derek W. Hood‡2
From the‡Molecular Infectious Diseases Group, University of Oxford Department of Paediatrics, Weatherall Institute of Molecular
Medicine, John Radcliffe Hospital, Headington, Oxford, OX3 9DS, United Kingdom and §Institute for Biological Sciences, National
Research Council, Ottawa, Ontario, K1A OR6, Canada
The lipopolysaccharide (LPS) of non-typeable Haemophi-
lus influenzae (NTHi) can be substituted at various positions
by N-acetylneuraminic acid (Neu5Ac). LPS sialylation plays
an important role in pathogenesis. The only LPS sialyltrans-
ferase characterized biochemically to date in H. influenzae
is Lic3A, an -2,3-sialyltransferase responsible for the addi-
tion of Neu5Ac to a lactose acceptor (Hood, D.W., Cox, A. D.,
Gilbert, M., Makepeace, K., Walsh, S., Deadman, M. E., Cody,
A., Martin, A., Månsson, M., Schweda, E. K., Brisson, J. R.,
Richards, J. C., Moxon, E. R., and Wakarchuk, W. W. (2001)
Mol. Microbiol. 39, 341–350). Here we describe a second sial-
yltransferase, Lic3B, that is a close homologue of Lic3A and
present in 60% of NTHi isolates tested. A recombinant form
of Lic3B was expressed in Escherichia coli and purified by
affinity chromatography. We used synthetic fluorescent
acceptors with a terminal lactose or sialyllactose to show that
Lic3B has both -2,3- and -2,8-sialyltransferase activities.
Structural analysis of LPS from lic3Bmutant strains of NTHi
confirmed that only monosialylated species were detectable,
whereas disialylated species were detected upon inactivation
of lic3A. Furthermore, introduction of lic3B into a lic3B-de-
ficient strain background resulted in a significant increase in
sialylation in the recipient strain. Mass spectrometric analy-
sis of LPS indicated that glycoforms containing two Neu5Ac
residues were evident that were not present in the LPS of the
parent strain. These findings characterize the activity of a
second sialyltransferase in H. influenzae, responsible for the
addition of di-sialic acid to the LPS. Modification of the LPS
by di-sialylation conferred increased resistance of the orga-
nism to the killing effects of normal human serum, as com-
pared with mono-sialylated or non-sialylated species, indi-
cating that this modification has biological significance.
Sialylation of lipopolysaccharide (LPS)3 is a widely conserved
structural modification among mucosal pathogens, with a
reported role in virulence in a number of organisms. In Hae-
mophilus influenzae LPS sialylation has been demonstrated to
be important in resistance to the killing effects of normal
human serum. A significant decrease in bacterial survival in
human serum was observed in sialylation-deficient mutants, in
which the CMP-Neu5Ac synthetase gene (siaB) had been dis-
rupted, compared with the wild-type organisms (2). Further-
more, the role of sialylation as a critical virulence factor in the
pathogenesis of experimental otitis media has been demon-
strated, Neu5Ac-deficient mutants of non-typeableH. influen-
zae (NTHi) were profoundly attenuated in a chinchillamodel of
infection (3). Related to this, it has been proposed that LPS
sialylation may be implicated in the formation of biofilms
(4–6). These studies provide evidence thatNeu5Ac-containing
LPS promotes bacterial persistence in vivo, potentially indicat-
ing a multi-faceted role for Neu5Ac in bacterial colonization
and disease.
Virtually all NTHi strains tested includeNeu5Ac in their LPS
(2, 7), but the patterns of sialylation and the repertoire of puta-
tive sialyltransferases differ between strains. Two common sia-
lylated species have been identified to date inH. influenzaeLPS,
sialylated lactose and sialylated lacto-N-neotetrose (2, 8, 9).
Lic3A, the only biochemically characterized sialyltransferase in
H. influenzae, is responsible for the addition of Neu5Ac in a
-2,3-linkage to a lactose acceptor on the LPS of H. influenzae
(1). Just within the 5 end of the lic3A open reading frame are
tandem repeats of the tetranucleotide 5-CAAT (10), and
hence, the encoded sialyltransferase is subject to phase varia-
tion. In some strain backgrounds, terminal N-acetyllac-
tosamine expressed as part of a lacto-N-neotetrose-like struc-
ture is also sialylated. Likely candidate enzymes to sialylate such
structures in H. influenzae are encoded by the sialyltransferase
gene homologues lsgB and siaA (originally termed orf Y) (6, 9,
11, 12). In aminority ofNTHi strains, disialic acid residues have
been detected in a small proportion of LPS glycoforms (2), indi-
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cating a potential role for another sialyltransferase in these
strains able to use Neu5Ac as an acceptor. Alternatively, a sial-
yltransferase enzyme capable of performing both reactionsmay
exist in some H. influenzae strains as has been reported in
Campylobacter jejuni (13), where a bifunctional sialyltransfer-
ase has been described. The findings from the current study
provide the first evidence that a bifunctional sialyltransferase
exists in H. influenzae.
EXPERIMENTAL PROCEDURES
Bacterial Strains andCultureConditions—Twenty-sixNTHi
isolates used in this study, designated 162, 176, 285, 375, 432,
477, 486, 667, 723, 981, 1003, 1008, 1124, 1158, 1159, 1180,
1181, 1200, 1207, 1209, 1231, 1232, 1233, 1247, 1268, and 1292,
were obtained from the Finnish OtitisMedia Study Group. Iso-
lates were obtained from the middle ears of patients with otitis
media and selected as representative of the genetic diversity of
H. influenzae after ribotyping analysis (14). Thirty-two type-
able H. influenzae isolates were also used in this study, repre-
senting serotypes a–f (15). H. influenzae was grown at 37 °C in
brain heart infusion broth supplemented with hemin (10
g/ml) and NAD (2 g/ml). Brain heart infusion plates were
prepared with 1% agar and supplemented with 10%
Levinthals base (16) and, when appropriate, kanamycin (10
g/ml), tetracycline (4 g/ml), or Neu5Ac (25 g/ml). Esch-
erichia coli strain DH5 was used to propagate plasmids and
was grown at 37 °C in LB broth (17) supplemented when
appropriate with ampicillin (100 g/ml), kanamycin (50
g/ml), or tetracycline (12 g/ml).
Mutation of lic3B and lic3A—Southern analysis identified a
novel 5-CAAT repeat tract which co-hybridized with a lic3A
probe. DNA from a genomic restriction digest of a size corre-
sponding to the positive hybridization signal was isolated after
electrophoresis of EcoRI-digested DNA. DNA was isolated
from the gel fragment using Qiaex resin (Qiagen), and purified
DNA was cloned into the pUC18 vector (Amersham Bio-
sciences). After transformation, transformants were screened
by colony hybridization (17) using a radiolabeled lic3A gene
probe. The sequence of the cloned insert was confirmed by
DNA sequencing using the BigDye Terminator Cycle Sequenc-
ing Ready Reaction DNA sequencing kit (ABI Prism, Applied
Biosystems) and an ABI 377 sequencer (ABI Prism,
PerkinElmer Life Sciences). The plasmid containing the novel
repeat-associated locus, lic3B, was designated pAA2. The
cloned lic3B gene from NTHi isolate 375, contained within
pAA2, was disrupted by digestion with restriction endonucle-
ase BglII and insertion of a kanamycin resistance cassette,
released from pUC4Kan (Amersham Biosciences) by digestion
with BamHI, to give plasmid pAA2kan. To construct lic3A
mutants, the cloned lic3A gene previously described (1) was
inactivated after digestion with BglII by insertion of a tetracy-
cline resistance cassette derived from Tn10 to give plasmid
plic3Atet. After transformation into E. coli, all mutant strains
were confirmed by restriction and PCR analyses.
Construction of Sialyltransferase Mutant Strains of NTHi—
Mutant strains were constructed inNTHi isolates 375 and 1003
after transformation by the MIV procedure (18). All transfor-
mantswere confirmed by re-culturing on the appropriate selec-
tive media and by PCR analyses of both the lic3A and lic3B loci.
Mutant strain 375lic3A had previously been constructed (1),
and to make a 1003lic3Amutant, isolate 1003 was transformed
with plasmid plic3Atet. To construct lic3Bmutants, pAA2kan,
containing the interrupted lic3B gene, was used to transform
NTHi isolates 375 and 1003. In this case, transformants were
further confirmed by Southern analysis. To construct a
375lic3Alic3B double mutant, a 375lic3B mutant strain was
transformed with linearized plic3Atet. To construct a
1003lic3Alic3B double mutant, strain 1003lic3A was trans-
formed with chromosomal DNA isolated from strain
1003lic3B. Mutant strain 375siaB has been previously
described (2). To construct a 1003siaB mutant, plasmid pDJ1,
containing the siaB gene, inactivated by insertion of a kanamy-
cin resistance cassette (2) was used to transform NTHi isolate
1003.
Transfer of lic3B into a lic3B-deficient Strain Background—A
kanamycin resistance cassette was inserted into the bipA gene
(HI0864), the gene upstream of lic3B, in plasmid pAA2 to act as
a selectable marker after transformation. Plasmid pAA2 was
digested with NcoI, and a BamHI-digested kanamycin resist-
ance cassette from pUC4Kan was inserted at the site. Plasmid
pAA2bipAkan was verified by restriction and PCR analyses,
then used to transformNTHi isolate 1003. Chromosomal DNA
isolated from 1003bipA was used to transform strains Rd and
RdlgtC (1). Transformants in each case were confirmed by PCR
analysis.
Analysis of LPS by Electrophoresis—Bacterial lysates were
prepared from cells grown overnight on brain heart infusion
plates supplemented with Neu5Ac, then suspended in phos-
phate-buffered saline (pH 5.8) to a concentration with an
absorbance of 1 at 260 nm. Lysates were then treated with
neuraminidase and analyzed by Tricine-SDS-PAGE (19) and
staining with silver (Quicksilver; Amersham Biosciences). The
neuraminidase, purified from Clostridium perfringens, cleaves
terminal sialic acids bound to oligosaccharides.
Structural Analysis of LPS—Structural characterization of
LPS was achieved using electrospray ionization-MS tech-
niques, as described previously (8). Briefly, LPS was O-deacyl-
ated by treatment with anhydrous hydrazine at 37 °C for 1 h.
Samples were analyzed in the negative ion mode by using a
Prince CE system (Prince Technologies, TheNetherlands) cou-
pled to an API 3000 mass spectrometer (Applied Biosystems/
Sciex, Concord, Canada) via a microIonSpray interface. The
separations were obtained on90-cm-length bare fused-silica
capillary using 30 mM morpholine in deionized water, pH 9.0,
containing 5% methanol. A voltage of 30 kV was applied at the
injection, and a sheath solution (isopropanol-methanol, 2:1)
was delivered at a flow rate of 1.0 l/min.
Expression and Purification of Recombinant Lic3A and
Lic3B—The lic3A and lic3B genes were amplified by PCR from
NTHi isolate 375 chromosomal DNA using Pwo polymerase.
The primersHI-06 (5-CTTAGGAGGTCATATGTCAAAGT-
CTGTCATTATTGCAGGTAATGG 3; the NdeI site is in ital-
ics) and HI-07 (5-CCTAGGTCGACCTAATCCCATTTTCT-
TGATTTTAAGGCGTG 3; the SalI site is in italics) were used
to amplify the lic3A gene. The following primers were used to
amplify lic3B; HI-15 (5-CTTAGGAGGTCATATGTCAAAG-
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CCTGTCATTATTGCAGGTAATGG-3; the NdeI site is in
italics) andHI-16 (5-CCTAGGTCGACTTATTTGCGTAGT-
CTCATTTTCTTTGC 3; the SalI site is in italics). The PCR
products were digested with NdeI and SalI and cloned in
pCWori(lacZ) containing the sequence encoding theE. coli
maltose-binding protein (MalE) (without the leader peptide)
and the thrombin cleavage site. E. coli AD202 strains contain-
ing either construct HST-06 (lic3B from NTHi isolate 375 in
pCWori) or HST-08 (lic3A from NTHi isolate 375 in
pCWori) were grown in 2 YTmedium (17) containing 150
g/ml ampicillin and 2 g/liter glucose. The cultures were incu-
bated at 37 °C until A600  0.35, induced with 1 mM isopropyl
1-thio--D-galactopyranoside, and then incubated overnight at
25 °C. The cellswere brokenusing anAvestinC5Emulsiflex cell
disruptor (Avestin, Ottawa, CA), and the MalE-Lic3A and
MalE-Lic3B fusions were purified by affinity chromatography
on amylose resin following the manufacturer’s instructions
(New England Biolabs, Beverly, MA).
Enzymatic Assay Conditions—The sialyltransferase assays
were performed at 37 °C for 5 min. The -2,3-sialyltransferase
activity was assayed using CMP-Neu5Ac as donor and Gal-
1,4-Glc-FCHASE as acceptor in 50mMHepes, pH 7.5, contain-
ing also 10 mM MnCl2. The -2,8-sialyltransferase activity was
assayed using CMP-Neu5Ac as donor and Neu5Ac-2–3-
Gal-1,4-Glc-FCHASE as acceptor, in 50 mM Hepes, pH 7.5,
containing also 10 mM MnCl2. The transialidase activity was
assayed at 37 °C for 20min using Neu5Ac-2–3-Gal-1,4-Glc-
FCHASE as donor and CMP as acceptor in 50 mMMes, pH 6.0,
containing also 10mMEDTA.All the reactionswere stopped by
the addition of acetonitrile (25% final concentration). The puri-
fied enzymes were diluted to observe between 3 and 10% con-
version of the substrate into product during the incubation
times indicated above. The samples were analyzed by capillary
electrophoresis as described previously (31). Quantitation of
the reactionswas performed by integration of the capillary elec-
trophoresis trace peaks using the MDQ 32 Karat software
(Beckman, CA). The sialyltransferase and transialidase activi-
ties are expressed in milliunits (nmol of product/min)/mg of
purified fusion proteins.
Serum Bactericidal Assay—Bacteria cultured to mid-log
phase in brain heart infusion broth supplementedwithNeu5Ac
(100 g/ml) were resuspended in phosphate-buffered saline.
106 organisms were taken and incubated in 10% pooled normal
human serum for 30 min. After incubation, surviving bacteria
were enumerated by dilution and culture on plates.
RESULTS
ANovel LocusContaining a 5-CAATTetranucleotide Repeat
Tract Is Homologous to lic3A—A comprehensive survey of tet-
ranucleotide repeats in a set of 25 NTHi isolates by Southern
analysis identified a novel lic3A homologue (20). Several NTHi
isolates exhibited two restriction fragments that hybridized
correspondingly to both an internal lic3A probe and a (5-
CAAT)5 oligonucleotide probe. The novel lic3A hybridizing
restriction fragment from NTHi isolate 375, i.e. that which
showed no equivalent banding pattern in identical hybridiza-
tion analyses with the genome sequenced strain, Rd, was cloned
to give plasmid pAA2. After DNA sequencing of the cloned
insert, an open reading frame encoding a protein of 333 amino
acids with high homology to Lic3A was identified. This Lic3A
homologue was flanked upstream by HI0865, a GTP-binding
protein with homology to bipA (21), and downstream by
HI0864, a glutamine synthetase gene, glnA. glnA is immediately
adjacent to the hmg locus (HI0866 to HI0874), which contains
multiple genes responsible for the synthesis and incorpora-
tion of the lacto-N-neotetrose-like structure, expressed on the
LPS of a range of capsular and NTHi strains (12). This second
copy of lic3A has been designated lic3B.
Primers HI0864 and HI0865 (supplemental data), designed
against the DNA sequences flanking lic3Bwere used to amplify
by PCR portions of HI0864 and HI0865 that are contiguous in
the Rd genome sequence and any DNA located between them.
11 of 25 NTHi isolates tested gave an amplification product of
1.6 kilobases, indicating a gene organization like that of strain
Rd; however, in 14 of the isolates a product of 2.6 kilobases was
amplified indicating an insertion of DNA in this region of the
chromosome. Upon Southern analysis, all of the larger PCR
amplification products hybridized to a lic3A probe, indicating
that the inserted DNA is conserved between strains (data not
shown). A survey of the presence of lic3B in 32 H. influenzae
capsular strains, representing serotypes a–f, by PCR amplifica-
tion indicated that lic3B was present in a lower proportion
(31%) of capsular H. influenzae strains than observed with
NTHi (60%). The lic3B gene was found to be absent from the
serotype c and d strains tested and was present in 86% of sero-
type a strains, 50% of serotype f strains, 25% of serotype e
strains, and 17% of serotype b strains tested (data not shown).
The lic3A gene is phase variably expressed due to a 5-CAAT
tetranucleotide repeat tract located within the reading frame
(22). Lic3B also contains a 5-CAAT repeat tract located at the
same position relative to the downstream open reading frame.
The DNA sequence of the tetranucleotide repeat tracts within
lic3A and lic3B in the 25 NTHi isolates was obtained, and the
number of repeated motifs was found to vary from 14 to 41 in
lic3A and from 12 to 28 in lic3B. For both genes two of the three
possible reading frames are predicted to allow for translation of
full-length gene products from alternative initiation codons
(ATG1 and ATG2), immediately upstream of the repeats. The
amino acid sequences of Lic3A (GenBankTM accession number
DQ447744) and Lic3B (GenBankTM accession number
DQ444277) from NTHi isolate 375 share 93% similarity and
91% identity (supplemental data).
Disruption of lic3B Eliminates Disialylation of LPS—To
investigate the function of lic3B, the cloned gene from NTHi
isolate 375 was inactivated by insertion of a kanamycin resist-
ance cassette then used to transform NTHi isolates 375 and
1003. To confirm that only lic3B had been specifically targeted
and that lic3A had not been altered, PCR amplification using
lic3A- and lic3B-specific primers along with Southern hybrid-
ization analysis was used to confirm the integrity of the trans-
formants (data not shown). NTHi isolate 1003 was chosen as a
second strain background in which to study the function of
Lic3B since the detailed structure of the LPS has been deter-
mined (Fig. 1), and Neu5Ac occupies the same molecular envi-
ronment as in isolate 375, which is attached to the -galactose
of lactose attached to the distal heptose (23). In addition, disia-
Bifunctional LPS Sialyltransferase in H. influenzae
40026 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 281•NUMBER 52•DECEMBER 29, 2006
 at UQ Library on October 9, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
lylated species have also been detected in the LPS of this isolate
(23). To analyze LPS sialylation in a comprehensive manner in
these two NTHi isolates, mutant strains in which lic3A (1) and
siaB, the CMP-Neu5Ac synthetase gene, had been disrupted
were constructed along with a double lic3Alic3Bmutant.
Bacterial lysates prepared from wild-type isolates 375 and
1003 and mutant strains were electrophoresed to visualize LPS
profiles. LPS from the wild-type and lic3A and lic3B mutant
strains of NTHi 375 and 1003 was then purified, and the glycan
profiles were determined using electrospray ionization-MS
techniques (8). The LPS profile of wild-type isolate 1003 exhib-
its four bands; the upper two bands (bands 1 and 2 indicated on
Fig. 2a) were removed upon neuraminidase treatment, results
that are consistent with there beingmono- and disialylated spe-
cies (23). In 1003lic3A and 1003lic3B mutant strains only one
sialylated band (band 2 in Fig. 2a) was observed; the upper
sialylated band evident inwild-type 1003 LPS is absent from the
LPS profiles of the mutants. In the 1003lic3Alic3B mutant
strain all sialylated glycoforms are absent (Fig. 2b). Structural
analysis of the LPS of 1003lic3B revealed that glycoforms con-
taining only a single Neu5Ac residue are present in this strain,
whereas analysis of 1003lic3A-derived LPS identified disialy-
lated species (Table 1, top). The absence of the upper sialylated
band in the LPS profile of strain 1003lic3A may be due to
decreased levels of disialylation in this mutant strain compared
with wild type.
Wild-type isolate 375 displays a LPS electrophoretic profile
comprising three distinguishable bands, the upper of which is a
minor band that shifts inmolecular weight after neuraminidase
treatment (Fig. 2c). This minor upper band is believed to rep-
resent the highest molecular weight disialylated LPS species
present in this bacterium. The major middle band remains,
whereas a more intense lower band appears in neuraminidase-
treated LPS. Isolated 375 possesses monosialylated LPS species
and a minor proportion of disialylated species (2). In the
375lic3B mutant, the minor upper band observed with wild-
type LPS was not present, indicating the likely absence of disia-
lylated species in thismutant. However, a sialylation phenotype
was evident upon neuraminidase treatment; this shift in the
mobility of the LPS suggests that mono-sialylated species are
present in this mutant strain. In the 375lic3A mutant LPS sia-
lylation is significantly higher than that observed in wild type.
Neuraminidase treatment of this hypersialylated LPS resulted
in the loss of the intense upper bands. The profile of neuramin-
idase-treated 375lic3A LPS is altered from that of neuramini-
dase-treated 375 wild-type LPS; this result was unexpected and
cannot be simply explained. No sialylation phenotype was
observed on neuraminidase treatment of the LPS in the
375lic3Alic3B (Fig. 2c) or 375siaB mutant strains (data not
shown). Similar to our findings with NTHi 1003, mass spectro-
metric analysis of the LPS of 375lic3B revealed that glycoforms
containing only a single Neu5Ac residue are present in this
strain, whereas analysis of 375lic3A LPS identified disialylated
species (Table 1, bottom). In addition, data from MS/MS anal-
ysis of 375lic3A LPS showed clear proof of the disialic acid gly-
coform consistent with Neu5Ac being directly linked to
Neu5Ac in the LPS molecule (data not shown).
Measurement of Sialyltransferase Activity of Lic3B—Lic3A
andLic3B fromNTHi isolate 375were expressed inE. coli fused
with the maltose-binding protein and purified on amylose
resin. In both cases the construct was made without the
5-CAAT repeats to minimize the effect of phase variation in
the recombinant constructs. The 5-CAAT repeats encode cor-
responding SINQ repeats in the amino acid sequence and their
deletion resulted in the truncation of 32 and 35 residues at the
FIGURE 1. Schematic representation of the LPS structure of NTHi isolate
1003aspresented inMånsson et al. (23). The site of attachment ofNeu5Ac,
as shown here for NTHi isolate 1003, is identical in the LPS of NTHi isolate 375
(2). The site of action of the glycosyltransferase, LgtC, is also indicated.
FIGURE 2. Electrophoretic profiles of LPS isolated from NTHi isolate 1003 and
derivedmutant strains inwhichputative sialyltransferase encodinggenes are
disrupted (panel a, lanes 1and2, 1003wild type; lanes3and4, 1003lic3A; lanes
5 and 6, 1003lic3B and panel b, lanes 1 and 2, 1003lic3A; lanes 3 and 4,
1003lic3Alic3B). NTHi isolate 375 andderivedmutant strains inwhichputative
sialyltransferaseencodinggenesaredisrupted (panel c, lanes 1and2, 375wild
type; lanes 3 and 4, 375lic3A; lanes 5 and 6, 375lic3B; lanes 7 and 8,
375lic3Alic3B), andH. influenzae strain Rd and the derivedmutant strains con-
taining themarked lic3B allele, RdbipAlic3B andRdbipAlgtClic3B (panel
d, lanes 1 and 2, Rd wild type; lanes 3 and 4, RdbipAlic3B1; lanes 5 and 6,
RdbipAlic3B2; lanes 7 and 8, RdbipA
lgtClic3B1; lanes 9 and 10,
RdbipAlgtClic3B2). A pair of profiles, without () and with () neuramin-
idase treatment, are shown for each strain, In panels a and c, distinct LPS
glycoforms are indicated by numbered arrows.
Bifunctional LPS Sialyltransferase in H. influenzae
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N termini of Lic3A and Lic3B, respectively. We assayed the
sialyltransferase activity of purified recombinant Lic3A and
Lic3B with fluorescent model compounds (Table 2). Both
Lic3A and Lic3B transfer sialic acid to lactose (Lac)-FCHASE
(Gal-1,4-Glc-FCHASE), whereas only Lic3B transfers to sia-
lyllactose-FCHASE (NeuAc-2,3-Lac-FCHASE). These pro-
files of activities suggest that Lic3A can transfer sialic acid only
to terminal galactose residues, whereas Lic3B can transfer sialic
acid either to a terminal galactose residue or to a terminal
Neu5Ac residue. We have shown that Lic3B can form disialic
acid on a terminal galactose residue by adding sequentially two
Neu5Ac residues using CMP-Neu5Ac as donor. After a 120-
min incubation time, we observed a distribution of 24.2%
Lac-FCHASE, 65% Neu5Ac-2,3-Lac-FCHASE, and 10.8%
Neu5Ac-2,8-Neu5Ac-2,3-Lac-FCHASE (supplemental data).
Addingmore enzyme or donor did not significantly increase the
yield of sialylated products, which suggested that the reaction
reached an equilibrium between the acceptor and the sialylated
products. While assaying Lic3A activity with siallylactose-
FCHASE as acceptor, a significant production of Lac-FCHASE
rather than the transfer of a second sialic acid was observed.
This “sialidase” activity is 4.6-fold higher when it is assayed in
the presence of CMP. Thus, Lic3A has significant transialidase
activity and performs the “backward” reaction in the presence
of sialyllactose andCMP. It is likely that there is a small amount
of CMP in the CMP-Neu5Ac used as donor, and this explains
TABLE 1
Negative ion electrospray-MS data and proposed compositions ofO-deacylated LPS from H. influenzae strains 1003 wild-type (wt), 1003lic3A,
1003lic3B, and 1003lic3Alic3B (top) and 375 wt, 375lic3A, 375lic3B, and 375lic3Alic3B (bottom)
Averagemass units were used for calculation of molecular weight based on proposed composition as follows: Lipid A-OH, 953.00 Da; hexose (Hex), 162.15 Da; Hep, 192.17
Da; Kdo-P, 300.13 Da; PEtn, 123.05 Da; PCho, 165.05 Da; sialic acid (Sial), 291.05 Da.
Strain Observed ions Observed mass Calculated mass Relative intensity a Proposed composition
M-3H3 M-2H2
Da Da %
1003
wt 854.3 1281.7 2565.7 2565.1 22 PCho, 2Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
908.3 1363.1 2728.0 2727.3 9 PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
1005.4 1508.6 3019.2 3019.4 43 Sial, PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
1102.7 3311.1 3311.6 26 2Sial, PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
lic3A 854.4 1282.1 2566.2 2565.1 27 PCho, 2Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
908.5 1362.8 2728.0 2727.3 9 PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
1005.6 1508.8 3019.7 3019.4 46 Sial, PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
1102.7 3311.1 3311.6 18 2Sial, PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
lic3B 854.3 1282.1 2566.1 2565.1 20 PCho, 2Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
908.4 1362.8 2727.9 2727.3 13 PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
1005.5 1508.7 3019.5 3019.4 67 Sial, PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
lic3A lic3B 854.3 1282.1 2566.1 2565.1 47 PCho, 2Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
908.4 1363.2 2728.3 2727.3 53 PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
375
wt 962.6 1444.2 2890.6 2889.5 45 PCho, 4Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
1003.3 1505.7 3013.1 3012.5 41 PCho, 4Hex, 3Hep, 3PEtn, Kdo-P, Lipid A-OH
1005.7 1508.7 3019.7 3019.4 9 Sial, PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
1102.7 3311.1 3311.6 5 2Sial, PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
lic3A 908.4 1362.7 2727.9 2727.3 18 PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
949.5 1424.6 2851.3 2850.4 9 PCho, 3Hex, 3Hep, 3PEtn, Kdo-P, Lipid A-OH
962.4 1444.2 2890.8 2889.5 7 PCho, 4Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
1005.5 1509.0 3019.9 3019.4 23 Sial, PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
1046.7 3143.1 3142.5 4 Sial, PCho, 3Hex, 3Hep, 3PEtn, Kdo-P, Lipid A-OH
1102.7 1654.7 3311.2 3311.6 23 2Sial, PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
1143.7 3434.1 3434.7 16 2Sial, PCho, 3Hex, 3Hep, 3PEtn, Kdo-P, Lipid A-OH
lic3B 962.5 1444.2 2890.5 2889.5 63 PCho, 4Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
1003.6 1505.7 3013.1 3012.5 31 PCho, 4Hex, 3Hep, 3PEtn, Kdo-P, Lipid A-OH
1005.6 3019.8 3019.4 6 Sial, PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
lic3A lic3B 854.3 1282.1 2566.1 2565.1 31 PCho, 2Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
895.3 1343.6 2689.1 2688.2 16 PCho, 2Hex, 3Hep, 3PEtn, Kdo-P, Lipid A-OH
908.3 1363.2 2728.2 2727.3 22 PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
949.5 1424.7 2851.5 2850.4 9 PCho, 3Hex, 3Hep, 3PEtn, Kdo-P, Lipid A-OH
962.4 1444.1 2890.2 2889.5 13 PCho, 4Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
1003.5 1505.3 3013.0 3012.5 9 PCho, 4Hex, 3Hep, 3PEtn, Kdo-P, Lipid A-OH
a Relative intensities were calculated from the average of the integrals of the double-, triple-, and quadruple-charged ions as appropriate.
TABLE 2
Comparison of the activity of the Lic3A and Lic3B sialyltransferases from NTHi 375
Lic3A and Lic3B were expressed in E. coli as fusions with the maltose-binding protein in the vector pCWori and purified on amylose resin.
Sialyltransferase Specific activity
-2,3-Sialyltransferasea -2,8-Sialyltransferaseb Transialidasec
milliunits/mg
Lic3A 240.9 Not detectable 5.6
Lic3B 100.0 5.6 0.6
a The -2,3-sialyltransferase activity was assayed using CMP-Neu5Ac as donor andGal-1,4-Glc-FCHASE as acceptor. The sialic acid (Neu5Ac) residue was transferred to the
Gal residue (in bold).
b The -2,8-sialyltransferase activity was assayed using CMP-Neu5Ac as donor and Neu5Ac-2–3-Gal-1,4-Glc-FCHASE as acceptor. The sialic acid (Neu5Ac) residue was
transferred to the Neu5Ac residue (in bold).
c The transialidase activity was assayed using Neu5Ac-2–3-Gal-1,4-Glc-FCHASE as donor and CMP as acceptor.
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why we observed degradation of sialyllactose when we assayed
Lic3A for -2,8-sialyltransferase activity. This transialidase
activity is much less significant in the case of Lic3B (Table 2).
Transfer of lic3B into a lic3B-deficient Strain Background
Confers Increased Sialylation—To further analyze the function
of Lic3B, the lic3B gene was transferred into a lic3B-deficient
strain background, strainRd, to determinewhether a sialylation
phenotype specific to lic3B would be acquired. An antibiotic
resistance cassette was first introduced into bipA (HI0864), the
gene upstream of lic3B, to act as a selectablemarker after trans-
formation. The electrophoretic profiles of 1003bipA mutants
were examined to confirm that inactivation of bipA had no
detectable effect on the LPS profiles when compared with wild
type (data not shown). Transformants containing the lic3B
allele in strain Rd exhibited increased LPS sialylation (Fig. 2d)
when compared with the parent strain. Three bands are detect-
able in the LPS profile of wild-type strain Rd, the middle of
which is sialylated, as illustrated by the fact that treatment with
neuraminidase decreases the intensity of this band. The
decrease in intensity of this band rather than complete removal
on treatment with neuraminidase likely indicates that a non-
sialylated band co-migrates with the sialylated LPS glycoform
in this strain background. In the RdbipAlic3B mutants the
upper of the three bands is also sialylated, with a decrease in
intensity of these two upper bands observed upon neuramini-
dase treatment. To clarify this observation, strain RdlgtC, con-
taining a mutation in the gene encoding the -1,4-galactosyl-
transferase, lgtC, was used as this precludes any competition for
the lactose acceptor and the formation of non-sialylated exten-
sions. This has been shown to increase the proportion of
observed sialylated glycoforms (1). Two bands representing sia-
lylated glycoforms are evident in the RdbipAlgtClic3B
mutants that are both removed upon neuraminidase treatment
(Fig. 2d). These findings are consistent with our prediction that
the introduction of lic3B into strain Rd increases the degree and
complexity of LPS sialylation in that strain.
Mass spectrometric analysis of LPS isolated from strain
RdbipAlgtClic3B showed clear evidence of glycoforms
containing 1 and 2 sialic acid residues (Table 3). These glyco-
forms were present in relatively equal abundance. Only glyco-
forms displaying a single Neu5Ac residue were apparent upon
analysis of LPS isolated from strain RdlgtC (Table 3).
Serum Resistance of Sialyltransferase-deficient Strains—
Neu5Ac is known to influence the resistance of organisms to
the killing effect of human sera (2). The set of sialyltransferase
mutants in NTHi isolate 1003 were subject to bactericidal
assays to analyze the effect of inactivation of single and combi-
nations of putative sialyltransferase genes upon biological
activity of the LPS. The wild-type strain along with the siaB
mutant was included in these assays for comparison, and assays
were repeated multiple times. For NTHi isolate 1003, the wild
type strain was most resistant and the siaBmutant least resist-
ant (	2 log drop) to the killing effect of human sera (Fig. 3). The
1003lic3Alic3B doublemutant was sensitive to serum similar to
1003siaB. Lic3 single mutants displayed intermediate resist-
ance phenotypes. Student’s t test showed a significant differ-
ence (p 0.000336) between strains lacking sialic acid in their
LPS (1003lic3Alic3B and 1003siaB) compared with strains pos-
sessing 1 or 2 sialic acid residues in their LPS (wild-type 1003,
1003lic3A, 1003lic3B). The difference in serum resistance was
not statistically significant between the lic3A and lic3Bmutant
strains. However, a significant difference (p 0.05) was shown
betweenwild-type 1003 and the single lic3A and lic3Bmutants,
indicating that disruption of either one of these sialyltransfer-
ase genes reduces serum resistance significantly. The results
obtained in the serum resistance assay correlated well with the
LPS phenotypes described by the MS data. The most heavily
sialylated strains corresponded to the most serum-resistant
phenotypes, and the strains unable to sialylate LPS corre-
sponded to the most serum-sensitive phenotypes.
TABLE 3
Negative ion electrospray-MS data and proposed compositions ofO-deacylated LPS from H. influenzae strains Rd wild-type (wt), RdlgtC,
RdbipAlic3B, and RdbipAlgtClic3B
Averagemass units were used for calculation of molecular weight based on proposed composition as follows: Lipid A-OH, 953.00 Da; hexose (Hex), 162.15 Da; Hep, 192.17
Da; HexNAc, 203.19 Da; Kdo-P, 300.16 Da; PEtn, 123.05 Da; PCho, 165.05; Sial, 291.05 Da.
Strain Observed ions Observed mass Calculated mass Relative intensity Proposed composition
M-3H3 M-2H2
Da Da %
Rd wt 867.7 1302.1 2606.1 2604.2 10 PCho, 3Hex, 3Hep, PEtn, Kdo-P, lipid A-OH
908.4 1363.2 2728.2 2727.3 24 PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
962.5 1444.2 2890.5 2889.5 22 PCho, 4Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
989.0 2970.0 2969.6 12 PCho, HexNAc, 4Hex, 3Hep, PEtn, Kdo-P, Lipid A-OH
1005.6 1508.5 3019.6 3019.4 15 Sial, PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
1030.2 1545.7 3093.5 3092.7 17 PCho, HexNAc, 4Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
RdlgtC 853.6 2563.8 2565.1 33 PCho, 2Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
867.0 1301.4 2604.4 2604.2 14 PCho, 3Hex, 3Hep, PEtn, Kdo-P, Lipid A-OH
908.4 1363.1 2728.0 2727.3 48 PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
1509.5 3021.0 3019.4 5 Sial, PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
RdbipA 908.4 1362.7 2727.9 2727.3 15 PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
lic3B 962.4 1443.7 2889.8 2889.5 17 PCho, 4Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
989.9 2972.7 2969.6 12 PCho, HexNAc, 4Hex, 3Hep, PEtn, Kdo-P, Lipid A-OH
1005.5 3019.5 3019.4 12 Sial, PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
1030.3 1545.3 3093.1 3092.7 15 PCho, HexNAc, 4Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
1102.7 3311.1 3311.6 29 2Sial, PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
RdlgtC 908.4 1363.2 2728.3 2727.3 50 PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
bipA lic3B 1005.5 1508.6 3019.4 3019.4 20 Sial, PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
1102.7 3311.1 3311.6 30 2Sial, PCho, 3Hex, 3Hep, 2PEtn, Kdo-P, Lipid A-OH
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DISCUSSION
Sialic acid has been implicated as a virulence factor in several
bacterial species. The mechanism by which sialylation of LPS
contributes to both the commensal and pathogenic behavior of
NTHi might be key to understanding the pathogenesis of dis-
ease caused by this organism. Sialylation of LPS is a critical
virulence factor in vivo required for NTHi to cause otitis media
in a chinchilla model of infection (3). H. influenzae lacks the
genes required forde novo synthesis ofNeu5Ac andmust there-
fore access an external source of the sugar as either a substrate
for growth (24) or for modification of LPS via a number of
specific sialyltransferases. Sialyltransferases determine the fre-
quency and pattern of LPS sialylation across NTHi strains.
In this study we investigated the function of the sialyltrans-
ferase Lic3B, encoded by a gene identified as a close homologue
of lic3A. lic3A encodes the only previous biochemically charac-
terized-2,3-sialyltransferase required for sialylation of lactose
in H. influenzae LPS (2). Lic3B and Lic3A are closely related
enzymes that have overlapping functions. Evidence presented
here from biochemical, structural, and mutational analyses
supports the role of Lic3B as a bifunctional enzyme with -2,3-
and -2,8-sialyltransferase activity able to utilize both terminal
galactose of lactose and Neu5Ac of sialyllactose as acceptor
molecules. The recombinant purified Lic3A protein showed no
activity on sialyllactose (1). Mass spectrometric analysis of LPS
isolated from lic3A and lic3B mutant strains of NTHi demon-
strated that upon inactivation of lic3B onlymonosialylated spe-
cies were detectable, whereas after inactivation of lic3A, disia-
lylated species were detected. Furthermore, the introduction of
lic3B into a lic3B-deficient strain background revealed a signif-
icant increase in LPS sialylation. The presence of disialylated
species was confirmed in this modified strain.
Bifunctional sialyltransferase enzymes have previously been
described in other mucosal pathogens including C. jejuni and
Neisseria meningitidis (13, 25). In C. jejuni, the cstI gene
encodes an -2,3-sialyltransferase, and the cstII gene encodes
either a monofunctional -2,3-sialyltransferase or a bifunc-
tional enzyme with -2,3- and -2,8-sialyltransferase activity,
depending on the allele of Cst-II (13). Interestingly, Lic3A and
Lic3B of H. influenzae and Cst-I and Cst-II of C. jejuni are
classified in the same family of carbohydrate-active enzymes as
defined by the CAZy classification system, indicating the relat-
edness of these enzymes. In N. meningitidis, the lst gene
encodes an enzyme with -2,3-sialyltransferase activity in
strainMC58 (L3 immunotype) and a bifunctional enzyme with
-2,3- and -2,6-sialyltransferase activity in strain 126E (L1
immunotype) (25). The monofunctional enzyme from MC58
can be changed into a bifunctional 126E-like enzyme by site-
directedmutagenesis of a single amino acid (25).Work is ongo-
ing to determine the specific amino acids that confer bifunc-
tionality of the Lic3B sialyltransferase enzyme.
A strong correlation exists between the epitopes of H. influ-
FIGURE 3. Resistance of NTHi isolate 1003 mutated in sialyltransferase genes or the CMP-Neu5Ac synthetase gene to the killing effect of pooled
human serum. Results are expressed as number of surviving bacteria after incubation with human serum. Results are expressed as average values from two
experiments each done in triplicate; S.D. are shown. cfu, colony-forming units.
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enzae LPS that are known to have specific biological function
and synthesis dependent upon phase variable gene expression.
Lic3A and likely Lic3B are both expressed in a phase variable
manner. Indeed, all enzymes competing to use the terminal
lactose off the distal heptose as an acceptor are phase variably
expressed, as is Lic2A, which adds the terminal -galactose of
the lactose itself. This makes the sialyllactose or the alternative
digalactoside synthesized when LgtC is dominant, potentially
one of the most highly variable LPS epitopes expressed by
NTHi. This likely indicates an advantage to the organism in
expressing Neu5Ac or, alternatively, a digalactoside in its LPS
under certain conditions. These variable conditionsmay corre-
spond to changing microenvironments in different host com-
partments or between hosts. No information is available on the
level of expression of the lic3A and lic3B genes, but an added
level of complexity may be inferred by the fact that both genes
have two potential initiation codons. In other phase-variable
genes it has been shown that different reading frames can re-
late to differing levels of expression of the gene product (26, 27).
There may, therefore, be modulation of LPS sialylation pheno-
types depending on the relative expression levels of both of
these genes.
The lic3A gene is present in all strains tested, whereas lic3B is
present in only a proportion. It is not clear whether lic3B arose
by horizontal transfer or by duplication within the genome.
Because of the proximity of lic3B to the hmg locus, it is possible
that these isolates belong to the same lineage where some com-
plex ancestral insertion/deletion event has occurred. Because of
the lack of redundancy generally associated with pathogenic
organisms containing small genomes, it is unlikely that two
alleles carrying out identical functions would be maintained
within the genome. It has been demonstrated in other orga-
nisms that minor sequence changes can confer bifunctionality
of sialyltransferase genes (25). It would, therefore, be reasona-
ble to hypothesize that after gene duplication, minor sequence
changeswould have been sufficient to confer distinct functional
specificities of the Lic3A and Lic3B proteins, favoring themain-
tenance of the corresponding genes within the genome.
Two other putative sialyltransferases SiaA and LsgB can also
be present in NTHi isolates, but neither 375 nor 1003 contain
the siaA gene. The lsgB gene was mutated both singly and in
combination with the lic3A and lic3B sialyltransferase genes.
No effect on sialylation was observed when lsgBwasmutated in
our NTHi isolate backgrounds, confirming that Lic3A and
Lic3B alone are responsible for sialylation of sialyllactose. SiaA
and LsgB proteins may be involved in sialylation of the high
molecular weight glycoform expressed by some NTHi isolates
(12).
The findings from our study indicate that details of the path-
way and mechanism of LPS sialylation in NTHi isolate 375 is
somewhat more complex than other isolates studied. The un-
expected observation of a hypersialylated phenotype in the
375lic3A mutant could possibly be explained by the transiali-
dase activity of Lic3A under in vitro conditions. In addition to
this unexpected hypersialylated phenotype, inactivation of
putative sialyltransferase genes within this strain resulted in
some unexpected and variable alterations in the LPS profiles
between individual transformants that were seemingly not
directly related to sialylation. A degree of complexity in the
sialylation phenotype of mutant strains was also reported by
Jones et al. (9) upon investigation of the putative sialyltrans-
ferases, SiaA and LsgB, in strain A2. It could be hypothesized
that the changes observed in LPSphenotype between individual
transformants in NTHi 375 were due to concomitant phase
variation events in other LPS biosynthetic genes, perhaps
enhanced by an elevated switching rate of gene expression. A
further possibility is that changes in the expression of sialyl-
transferase enzymes could be exerted through some form of
transcriptional control of the relevant gene(s).
In this study a strong correlation was found between incor-
poration of Neu5Ac on LPS and serum resistance of NTHi, as
observed previously (2). It could be envisaged that Neu5Ac
would afford protection from human serum in an analogous
way to a capsule, potentially explaining the extra investment by
NTHi in the presentation of Neu5Ac on their cell surface. This
is apparent by the higher percentage ofNTHi strains possessing
the sialyltransferase gene, lic3B, comparedwith capsular strains
of H. influenzae and the fact that 25/25 NTHi isolates studied
contained Neu5Ac in their LPS (7). The mechanism by which
sialic acid contributes to serum resistance remains to be eluci-
dated. Other potential roles of LPS sialylation may be in mod-
ulating antigenic mimicry of LPS epitopes or by modulating
host interactions either by an indirect charge effect or by steric
hindrance. Sialylation of LPS produces a negative charge on the
bacterial surface potentially aiding evasion from phagocytic
cells in the host environment. It has been proposed that NTHi
forms a biofilm in vivo associated with increased sialylated LPS
glycoforms compared with in vitro grown organisms (5,
28–30). Although there has been no formal evidence of an
extracellular polysaccharidematrix, one of the cardinal features
of a biofilm, the sialylated LPS glycoforms of organisms in vivo
are clearly implicated in pathogenesis based on studies in a
chinchilla model of otitis media (3, 6).
The functional significance of expression of a sialylated LPS
phenotype in NTHi isolates may be dependent on the “total
package” of LPS glycoforms expressed at any given time in any
particular isolate in addition to the contribution of other sur-
face components. Because there are more complex patterns of
LPS glycoforms expressed by NTHi than by almost any other
mucosal pathogen that has been analyzed, it seems plausible
that this complexity might be a key factor in the adaptability of
these bacteria between compartments within and between
hosts.
Acknowledgments—We thank Marie-France Karwaski and Anna
Cunningham for expert technical assistance and Juhani Eskola and
the FinnishOtitisMedia StudyGroup for the provision of strains used
in this study.
REFERENCES
1. Hood, D.W., Cox, A. D., Gilbert, M., Makepeace, K.,Walsh, S., Deadman,
M. E., Cody, A., Martin, A., Månsson, M., Schweda, E. K., Brisson, J. R.,
Richards, J. C., Moxon, E. R., and Wakarchuk, W. W. (2001)Mol. Micro-
biol. 39, 341–350
2. Hood, D. W., Makepeace, K., Deadman, M. E., Rest, R. F., Thibault, P.,
Martin, A., Richards, J. C., and Moxon, E. R. (1999) Mol. Microbiol. 33,
Bifunctional LPS Sialyltransferase in H. influenzae
DECEMBER 29, 2006•VOLUME 281•NUMBER 52 JOURNAL OF BIOLOGICAL CHEMISTRY 40031
 at UQ Library on October 9, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
679–692
3. Bouchet, V., Hood, D.W., Li, J., Brisson, J. R., Randle, G. A., Martin, A., Li,
Z., Goldstein, R., Schweda, E. K., Pelton, S. I., Richards, J. C., and Moxon,
E. R. (2003) Proc. Natl. Acad. Sci. U. S. A. 100, 8898–8903
4. Swords, W. E., Moore, M. L., Godzicki, L., Bukofzer, G., Mitten, M. J., and
VonCannon, J. (2004) Infect. Immun. 72, 106–113
5. Greiner, L. L.,Watanabe,H., Phillips,N. J., Shao, J.,Morgan,A., Zaleski, A.,
Gibson, B. W., and Apicella, M. A. (2004) Infect. Immun. 72, 4249–4260
6. Jurcisek, J., Greiner, L., Watanabe, H., Zaleski, A., Apicella, M. A., and
Bakaletz, L. O. (2005) Infect. Immun. 73, 3210–3218
7. Bauer, S. H., Månsson, M., Hood, D.W., Richards, J. C., Moxon, E. R., and
Schweda, E. K. (2001) Carbohydr. Res. 335, 251–260
8. Cox, A. D., Hood, D. W., Martin, A., Makepeace, K. M., Deadman, M. E.,
Li, J., Brisson, J. R., Moxon, E. R., and Richards, J. C. (2002) Eur. J. Biochem.
269, 4009–4019
9. Jones, P. A., Samuels, N. M., Phillips, N. J., Munson, R. S., Jr., Bozue, J. A.,
Arseneau, J. A., Nichols, W. A., Zaleski, A., Gibson, B. W., and Apicella,
M. A. (2002) J. Biol. Chem. 277, 14598–14611
10. Weiser, J. N.,Maskell, D. J., Butler, P. D., Lindberg, A. A., andMoxon, E. R.
(1990) J. Bacteriol. 172, 3304–3309
11. Hood, D. W., Deadman, M. E., Allen, T., Masoud, H., Martin, A., Brisson,
J. R., Fleischmann, R., Venter, J. C., Richards, J. C., andMoxon, E. R. (1996)
Mol. Microbiol. 22, 951–965
12. Hood, D. W., Randle, G., Cox, A. D., Makepeace, K., Li, J., Schweda, E. K.,
Richards, J. C., and Moxon, E. R. (2004) J. Bacteriol. 186, 7429–7439
13. Gilbert, M., Brisson, J. R., Karwaski, M. F., Michniewicz, J., Cunningham,
A.M.,Wu, Y., Young, N.M., andWakarchuk,W.W. (2000) J. Biol. Chem.
275, 3896–3906
14. Cody, A. J., Field, D., Feil, E. J., Stringer, S., Deadman,M. E., Tsolaki, A. G.,
Gratz, B., and Bouchet, V. (2003) Infect. Genet. Evol. 3, 57–66
15. Musser, J. M., Kroll, J. S., Granoff, D. M., Moxon, E. R., Brodeur, B. R.,
Campos, J., Dabernat, H., Frederiksen, W., Hamel, J., Hammond, G.,
Hoiby, E. A., Jonsdottir, K. E., Kabeer, M., Kallings, I., Khan,W. N., Kilian,
M., Knowles, K., Koornhof, H. J., Law, B., Li, K. I., Montgomery, J., Patti-
son, P. E., Piffaretti, J. C., Takala, A. K., Thong,M. L.,Wall, R. A.,Ward, J. I.,
and Selander, R. K. (1990) Rev. Infect. Dis. 12, 75–111
16. Alexander,H. E. (1965) inBacterial andMycotic Infections ofMan (Dubos,
R. J., and Hirsch, J.G., eds) pp. 724–741, Pittman Medical Publishing Co.
Ltd., London
17. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989) Molecular Cloning: A
Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring
Harbor, NY
18. Herriott, R. M., Meyer, E. M., and Vogt, M. (1970) J. Bacteriol. 101,
517–524
19. Lesse, A. J., Campagnari, A. A., Bittner, W. E., and Apicella, M. A. (1990)
J. Immunol. Methods 126, 109–117
20. Fox, K. L., Yildirim, H. H., Deadman, M. E., Schweda, E. K., Moxon, E. R.,
and Hood, D. W. (2005)Mol. Microbiol. 58, 207–216
21. Qi, S-.Y., Li, Y., Szyroki, A., Giles, I. G., Moir, A., and O’Connor, C. D.
(1995)Mol. Microbiol. 17, 523–531
22. Szabo, M., Maskell, D., Butler, P., Love, J., and Moxon, R. (1992) J. Bacte-
riol. 174, 7245–7252
23. Månsson, M., Hood, D. W., Li, J., Richards, J. C., Moxon, E. R., and
Schweda, E. K. (2002) Eur. J. Biochem. 269, 808–818
24. Vimr, E., Lichtensteiger, C., and Steenbergen, S. (2000)Mol.Microbiol. 36,
1113–1123
25. Wakarchuk,W.W.,Watson, D., St.Michael, F., Li, J.,Wu, Y., Brisson, J. R.,
Young, N. M., and Gilbert, M. (2001) J. Biol. Chem. 276, 12785–12790
26. Weiser, J. N., Love, J. M., and Moxon, E. R. (1989) Cell 59, 657–665
27. Srikhanta, Y. N., Maguire, T. L., Stacey, K. J., Grimmond, S. M., and Jen-
nings, M. P. (2005) Proc. Natl. Acad. Sci. U. S. A. 102, 5547–5551
28. Raynor, M. G., Zhang, Y., Gorry, M. C., Chen, Y., Post, J. C., and Ehrlich,
G. D. (1998) J. Am. Med. Assoc. 279, 296–299
29. Post, J. C. (2001) Laryngoscope 111, 2083–2094
30. Ehrlich, G. D., Veeh, R., Wang, X., Costerton, J. W., Hayes, J. D., Hu, F. Z.,
Daigle, B. L., Ehrlich, M. D., and Post, J. C. (2002) J. Am. Med. Assoc. 287,
1710–1715
31. Wakarchuk, W. W. and Cunningham, A. M. (2003) Methods Mol. Biol.
213, 263–274
Bifunctional LPS Sialyltransferase in H. influenzae
40032 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 281•NUMBER 52•DECEMBER 29, 2006
 at UQ Library on October 9, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Table S1.  Primers used in PCR amplification of genes in H. influenzae.
Primer name Primer sequence Primers used to amplify
052560 5’ gcaggtaatggaacaagttt 3’
Blic3c 5’ catagaggactttctggc 3’
lic3f 5’ agtggcaactgtaatggg 3’
lic3g 5’ atatacaaacttcggcgg 3’
PB3 5’ caccccgactaaaaattgtt 3’
L3B1 5' ttttacacgctcaaggga 3'
lic3A
6024Q 5’ taaatcaggaaaataagacc 3’
6024R 5’ attattgtatttattcatcc 3’
lgtC
HI0864 5’ tgacgtatttaccttcttgtcc 3’
HI0865 5’ cgcatataattttctgcacg 3’
lic3B
lsgB 5’ aaaataaatgccctacag 3’
lsgC 5’ tttgttgtacaccattgc 3’
lsgB
siaB 5’ taaccgattgtatcatcc 3’
siaC 5’ gagagcgggttctaaagg 3’
siaB
GalEA 5’ caactaatggacatagcc 3’
GalEB 5’ tattttagaaatttcgcc 3’
galE
5’glnA 5’ ttttggtccagagcctgaat 3’
3’glnA 5’ catactctgtcaatacag 3’
glnA
2Fig. S1.  Amino acid sequence alignments of Lic3A and Lic3B from NTHi isolate 375 (the sequence is
shown from the initiation codon (ATG2) just upstream of the (SINQ)n repeats). The sequences of NTHi
375 Lic3A and Lic3B (GenBank accession numbers DQ447744 and DQ444277 respectively) are the
translated sequences correlating to 24 5’CAAT repeats being present. Homology is indicated by the level
of shading, no shading indicates non-synonymous changes.
3Fig. S2 Sequential addition of two Neu5Ac residues to the terminal galactose residue of Lac-FCHASE.
Purified recombinant Lic3B was incubated with a fluorescent lactose derivative and a 2-fold excess of
CMP-Neu5Ac. The reaction products were separated on a TLC silica plate. After a 120 min incubation
time, we observed a distribution of 24.2% Lac-FCHASE, 65% Neu5Ac?-2,3-Lac-FCHASE and 10.8 %
Neu5Ac?-2,8-Neu5Ac?-2,3-Lac-FCHASE.
Katherine Makepeace, James C. Richards, E. Richard Moxon and Derek W. Hood
Kate L. Fox, Andrew D. Cox, Michel Gilbert, Warren W. Wakarchuk, Jianjun Li,
: INCORPORATION OF DISIALIC ACIDHaemophilus influenzae
Identification of a Bifunctional Lipopolysaccharide Sialyltransferase in 
doi: 10.1074/jbc.M602314200 originally published online October 27, 2006
2006, 281:40024-40032.J. Biol. Chem. 
  
 10.1074/jbc.M602314200Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
Supplemental material:
  
 http://www.jbc.org/content/suppl/2006/10/31/M602314200.DC1.html
  
 http://www.jbc.org/content/281/52/40024.full.html#ref-list-1
This article cites 29 references, 12 of which can be accessed free at
 at UQ Library on October 9, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
